Your search returned 20 results.

Results
	1.	Anticancer therapy targeting the erbB family of receptor tyrosine kinases. [electronic resource] by Slichenmyer, W J Fry, D W Producer: 20011228 In: Seminars in oncology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Recent clinical advances with camptothecin analogues. [electronic resource] by Slichenmyer, W J Donehower, R C Producer: 19960418 In: Cancer treatment and research vol. 78 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Taxol: a new and effective anti-cancer drug. [electronic resource] by Slichenmyer, W J Von Hoff, D D Producer: 19920512 In: Anti-cancer drugs vol. 2 Availability: No items available. Save to lists Add to cart (remove)
	4.	New natural products in cancer chemotherapy. [electronic resource] by Slichenmyer, W J Von Hoff, D D Producer: 19910306 In: Journal of clinical pharmacology vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	The effect of cauterization of the rabbit ovary on adhesion formation. [electronic resource] by Awadalla, S G Mattox, J H Slichenmyer, W J Producer: 19861121 In: Fertility and sterility vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Chronic vasculitis causing unilateral ureteral stenosis. [electronic resource] by Goodman, G R Woodside, J R Slichenmyer, W J Producer: 19881110 In: Urology vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	CI-1033, a pan-erbB tyrosine kinase inhibitor. [electronic resource] by Slichenmyer, W J Elliott, W L Fry, D W Producer: 20011228 In: Seminars in oncology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Response of metastatic adenoid cystic carcinoma and Merkel cell tumor to high-dose melphalan with autologous bone marrow transplantation. [electronic resource] by Slichenmyer, W J LeMaistre, C F Von Hoff, D D Producer: 19920723 In: Investigational new drugs vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. [electronic resource] by Slichenmyer, W J Nelson, W G Slebos, R J Kastan, M B Producer: 19931001 In: Cancer research vol. 53 Availability: No items available. Save to lists Add to cart (remove)
	10.	The current status of camptothecin analogues as antitumor agents. [electronic resource] by Slichenmyer, W J Rowinsky, E K Donehower, R C Kaufmann, S H Producer: 19930301 In: Journal of the National Cancer Institute vol. 85 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Camptothecin analogues: studies from the Johns Hopkins Oncology Center. [electronic resource] by Slichenmyer, W J Rowinsky, E K Grochow, L B Kaufmann, S H Donehower, R C Producer: 19940929 In: Cancer chemotherapy and pharmacology vol. 34 Suppl Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Phase 1 drug interaction study of suramin and warfarin in patients with prostate cancer. [electronic resource] by Meyer, M Jeong, E Bolinger, B Chen, L Lenehan, P Slichenmyer, W Natale, R B Producer: 20010510 In: American journal of clinical oncology vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer. [electronic resource] by Bergan, R C Waggle, D H Carter, S K Horak, I Slichenmyer, W Meyers, M Producer: 20010607 In: Urology vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Serum prostate-specific antigen decline as a marker of clinical outcome in hormone-refractory prostate cancer patients: association with progression-free survival, pain end points, and survival. [electronic resource] by Small, E J McMillan, A Meyer, M Chen, L Slichenmyer, W J Lenehan, P F Eisenberger, M Producer: 20010329 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Pretreatment H2 receptor antagonists that differ in P450 modulation activity: comparative effects on paclitaxel clearance rates and neutropenia. [electronic resource] by Slichenmyer, W J Donehower, R C Chen, T L Bowling, M K McGuire, W P Rowinsky, E K Producer: 19950718 In: Cancer chemotherapy and pharmacology vol. 36 Availability: No items available. Save to lists Add to cart (remove)
	16.	Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer. [electronic resource] by Tolcher, A W Sugarman, S Gelmon, K A Cohen, R Saleh, M Isaacs, C Young, L Healey, D Onetto, N Slichenmyer, W Producer: 19990401 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Phase I and pharmacologic study of topotecan in patients with impaired renal function. [electronic resource] by O'Reilly, S Rowinsky, E K Slichenmyer, W Donehower, R C Forastiere, A A Ettinger, D S Chen, T L Sartorius, S Grochow, L B Producer: 19970103 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone. [electronic resource] by Small, E J Meyer, M Marshall, M E Reyno, L M Meyers, F J Natale, R B Lenehan, P F Chen, L Slichenmyer, W J Eisenberger, M Producer: 20000421 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Phase Ib study of tivozanib (AV-951) in combination with temsirolimus in patients with renal cell carcinoma. [electronic resource] by Fishman, M N Srinivas, S Hauke, R J Amato, R J Esteves, B Cotreau, M M Strahs, A L Slichenmyer, W J Bhargava, P Kabbinavar, F F Producer: 20131017 In: European journal of cancer (Oxford, England : 1990) vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Phase I and pharmacologic studies of topotecan in patients with impaired hepatic function. [electronic resource] by O'Reilly, S Rowinsky, E Slichenmyer, W Donehower, R C Forastiere, A Ettinger, D Chen, T L Sartorius, S Bowling, K Smith, J Brubaker, A Lubejko, B Ignacio, V Grochow, L B Producer: 19960711 In: Journal of the National Cancer Institute vol. 88 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 20 results.